Taho Pharmaceuticals Ltd. (TPEX:6467)
Taiwan
· Delayed Price · Currency is TWD 131.00
+2.50 (1.95%)
At close: Mar 6, 2026
Taho Pharmaceuticals Market Cap
Taho Pharmaceuticals has a market cap or net worth of 6.40 billion as of March 9, 2026. Its market cap has increased by 89.57% in one year.
Market Cap
6.40B
Enterprise Value
6.01B
Revenue
7.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
131.00
Market Cap Chart
Since August 14, 2014, Taho Pharmaceuticals's market cap has increased from 2.09B to 6.40B, an increase of 206.13%. That is a compound annual growth rate of 10.16%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 6.77B |
| Firich Enterprises | 6.68B |
| Gudeng Equipment Co., LTD. | 6.81B |
| Yeh Chiang Technology | 6.65B |
| Gus Technology | 6.82B |
| Hi-Lai Foods | 6.82B |
| Brogent Technologies | 6.82B |
| ChenFull Precision | 6.63B |